{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T05:22:47Z","timestamp":1740806567097,"version":"3.38.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,28]]},"DOI":"10.7759\/cureus.79807","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T08:25:57Z","timestamp":1740731157000},"source":"Crossref","is-referenced-by-count":0,"title":["An Unusual Case of Neuroendocrine Carcinoma of the Gastro-Esophageal Junction Complicated by Syndrome of Inappropriate Antidiuretic Hormone Secretion"],"prefix":"10.7759","author":[{"given":"Asmita","family":"Kulshrestha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deeksha","family":"Jawale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankit","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Bhoj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amitabh","family":"Pandagle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.35278","article-title":"The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide","volume":"156","author":"Filho AM","year":"2025","unstructured":"Filho AM, Laversanne M, Ferlay J, et al.. The GLOBOCAN 2022 cancer estimates: data sources, methods, and a snapshot of the cancer burden worldwide. Int J Cancer. 2025, 156:1336-1346. 10.1002\/ijc.35278","journal-title":"Int J Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7150\/jca.29483","article-title":"A 10-year population-based study of the differences between NECs and carcinomas of the esophagus in terms of clinicopathology and survival","volume":"10","author":"Cai W","year":"2019","unstructured":"Cai W, Ge W, Yuan Y, Ding K, Tan Y, Wu D, Hu H. A 10-year population-based study of the differences between NECs and carcinomas of the esophagus in terms of clinicopathology and survival. J Cancer. 2019, 10:1520-1527. 10.7150\/jca.29483","journal-title":"J Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2019.02.012","article-title":"A rare rarity: neuroendocrine tumor of the esophagus","volume":"137","author":"Giannetta E","year":"2019","unstructured":"Giannetta E, Guarnotta V, Rota F, de Cicco F, Grillo F, Colao A, Faggiano A. A rare rarity: neuroendocrine tumor of the esophagus. Crit Rev Oncol Hematol. 2019, 137:92-107. 10.1016\/j.critrevonc.2019.02.012","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal ID","year":"2020","unstructured":"Nagtegaal ID, Odze RD, Klimstra D, et al.. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020, 76:182-188. 10.1111\/his.13975","journal-title":"Histopathology"},{"key":"ref5","unstructured":"NET grade & stage - NETRF. (2025). Accessed. February 19, 2025: https:\/\/netrf.org\/for-patients\/net-grade-stage\/."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv505","article-title":"Risk factors for neuroendocrine neoplasms: a systematic review and meta-analysis","volume":"27","author":"Leoncini E","year":"2016","unstructured":"Leoncini E, Carioli G, La Vecchia C, Boccia S, Rindi G. Risk factors for neuroendocrine neoplasms: a systematic review and meta-analysis. Ann Oncol. 2016, 27:68-81. 10.1093\/annonc\/mdv505","journal-title":"Ann Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s44272-023-00004-6","article-title":"Neuroendocrine carcinomas of the esophagus: clinicopathological and immunohistochemical features of 43 cases","volume":"2","author":"Geng ZH","year":"2023","unstructured":"Geng ZH, Liu YL, Xu C, Zhu Y, Zhou PH, Cai MY. Neuroendocrine carcinomas of the esophagus: clinicopathological and immunohistochemical features of 43 cases. Clin Cancer Bulletin. 2023, 2:5. 10.1007\/s44272-023-00004-6","journal-title":"Clin Cancer Bulletin"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/jscr\/rjac582","article-title":"Oesophageal neuroendocrine tumours-case series of a rare malignancy","volume":"2022","author":"Nikolic AL","year":"2022","unstructured":"Nikolic AL, Gullifer J, Johnson MA, Hii MW. Oesophageal neuroendocrine tumours-case series of a rare malignancy. J Surg Case Rep. 2022, 2022:rjac582. 10.1093\/jscr\/rjac582","journal-title":"J Surg Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-19-2650","article-title":"Incidence, treatment, and survival analysis in esophageal neuroendocrine carcinoma population","volume":"9","author":"Li Z","year":"2020","unstructured":"Li Z, Hu J, Chen P, Zeng Z. Incidence, treatment, and survival analysis in esophageal neuroendocrine carcinoma population. Transl Cancer Res. 2020, 9:4317-4329. 10.21037\/tcr-19-2650","journal-title":"Transl Cancer Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.21037\/aoe-21-65","article-title":"Paraneoplastic syndromes in esophageal cancer-a narrative review","volume":"6","author":"Eochagain CM","year":"2023","unstructured":"Eochagain CM, Ronan K, Flynn C, Togher Z, Buchalter J, Lowery MA. Paraneoplastic syndromes in esophageal cancer-a narrative review. Ann Esophagus. 2023, 6:33. 10.21037\/aoe-21-65","journal-title":"Ann Esophagus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5049\/EBP.2022.20.1.21","article-title":"Korean Society of Nephrology 2022 recommendations on controversial issues in diagnosis and management of hyponatremia","volume":"20","author":"Lee Y","year":"2022","unstructured":"Lee Y, Yoo KD, Baek SH, et al.. Korean Society of Nephrology 2022 recommendations on controversial issues in diagnosis and management of hyponatremia. Electrolyte Blood Press. 2022, 20:21-38. 10.5049\/EBP.2022.20.1.21","journal-title":"Electrolyte Blood Press"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2147\/TCRM.S206066","article-title":"Syndrome of inappropriate antidiuretic hormone secretion (SIADH): optimal management","volume":"16","author":"Mentrasti G","year":"2020","unstructured":"Mentrasti G, Scortichini L, Torniai M, Giampieri R, Morgese F, Rinaldi S, Berardi R. Syndrome of inappropriate antidiuretic hormone secretion (SIADH): optimal management. Ther Clin Risk Manag. 2020, 16:663-672. 10.2147\/TCRM.S206066","journal-title":"Ther Clin Risk Manag"},{"key":"ref13","article-title":"Endocrine testing for the syndrome of inappropriate antidiuretic hormone secretion (SIADH)","author":"Pliquett RU","year":"2022","unstructured":"Pliquett RU, Oberm\u00fcller N. Endocrine testing for the syndrome of inappropriate antidiuretic hormone secretion (SIADH). In: Endotext [Internet]. Feingold KR, Anawalt B, Blackman MR, et al. (ed): MDText, South Dartmouth (MA); 2022."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1530\/EO-22-0056","article-title":"Hyponatraemia and the syndrome of inappropriate antidiuresis (SIAD) in cancer","volume":"2","author":"Donald DM","year":"2022","unstructured":"Donald DM, Sherlock M, Thompson CJ. Hyponatraemia and the syndrome of inappropriate antidiuresis (SIAD) in cancer. Endocr Oncol. 2022, 2:R78-R89. 10.1530\/EO-22-0056","journal-title":"Endocr Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/dote.12017","article-title":"A retrospective study of different treatments of limited-stage small-cell esophageal carcinoma and associated prognostic factor analysis","volume":"26","author":"Ding J","year":"2013","unstructured":"Ding J, Ji J, Zhu W, et al.. A retrospective study of different treatments of limited-stage small-cell esophageal carcinoma and associated prognostic factor analysis. Dis Esophagus. 2013, 26:696-702. 10.1111\/dote.12017","journal-title":"Dis Esophagus"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1177\/1010428317711313","article-title":"Progress in the treatment of esophageal neuroendocrine carcinoma","volume":"39","author":"Ma Z","year":"2017","unstructured":"Ma Z, Cai H, Cui Y. Progress in the treatment of esophageal neuroendocrine carcinoma. Tumour Biol. 2017, 39:1010428317711313. 10.1177\/1010428317711313","journal-title":"Tumour Biol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/336248-an-unusual-case-of-neuroendocrine-carcinoma-of-the-gastro-esophageal-junction-complicated-by-syndrome-of-inappropriate-antidiuretic-hormone-secretion","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T08:26:00Z","timestamp":1740731160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/336248-an-unusual-case-of-neuroendocrine-carcinoma-of-the-gastro-esophageal-junction-complicated-by-syndrome-of-inappropriate-antidiuretic-hormone-secretion"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.79807","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,28]]}}}